Αρχειοθήκη ιστολογίου

Τρίτη 6 Φεβρουαρίου 2018

Response to: baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

alertIcon.gif

Publication date: Available online 5 February 2018
Source:Annals of Allergy, Asthma & Immunology
Author(s): Allan T. Luskin, Bradley E. Chipps, Thomas B. Casale, Noelle M. Griffin




http://ift.tt/2BLh3RM

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου